Pyrophyte Acquisition Corp. II: enters business combination with Sakuu

What happened

• Pyrophyte Acquisition Corp. II reported that on Oct 14, 2026 it entered into a Business Combination Agreement with Sakuu Corporation and Pyrophyte Merger Sub, Inc. The agreement provides for Pyrophyte to domesticate from the Cayman Islands to Delaware, change its name to "Sakuu Holdings, Inc.", and for Merger Sub to merge with and into Sakuu with Sakuu surviving as a wholly owned subsidiary of Pyrophyte.
• The Business Combination Agreement provides for Sakuu equityholders to receive an aggregate of 60,000,000 newly issued New Pyrophyte Common Shares as Transaction Consideration, calculated by dividing $600,000,000 by $10.00 per share.

Key details

• Conversion and cancellations: each Pyrophyte Class A and Class B share will convert one-for-one into New Pyrophyte Common Shares at domestication; Sakuu Common Stock and Sakuu Preferred Stock will convert into New Pyrophyte Common Shares based on the Exchange Ratio (60,000,000 divided by the Fully Diluted Company Capitalization); certain shares held by Pyrophyte or its subsidiaries will be cancelled without consideration.
• Equity instruments: Company Options, Company Warrants, Company Convertible Notes and Company SAFEs will be converted, assumed, or terminated and converted into rights to New Pyrophyte Common Shares under specified formulas tied to the Exchange Ratio.
• Company incentive and earnout: New Pyrophyte will reserve 5,000,000 New Pyrophyte Common Shares under a company incentive pool if the closing price is at least $12.50 for any twenty Trading Days within any thirty consecutive Trading Day period during the five-year earnout period, and an additional 5,000,000 shares if the closing price is at least $15.00 for the same test.
• Closing conditions and timing: closing is subject to customary conditions including effectiveness of a Form S-4 registration statement and receipt of requisite shareholder approvals, listing approval on the NYSE or Nasdaq, expiration of applicable antitrust waiting periods, and, solely for Sakuu’s obligations, Net Closing Cash of at least $30,000,000. The Business Combination Agreement may be terminated if the transaction is not consummated on or prior to May 31, 2027.
• sponsor and support agreements: concurrently, Pyrophyte, the Sponsor (Pyrophyte Acquisition II LLC), and Sakuu entered into a Sponsor Support Agreement under which the Sponsor agreed to vote its Pyrophyte Shares in favor of the Business Combination, not redeem its Pyrophyte Shares, accept certain transfer restrictions and potential forfeiture of Pyrophyte Class B Shares committed to secure PIPE financing, and pay Pyrophyte Transaction Expenses in excess of the Pyrophyte Transaction Expense Cap.
• lock-up and shareholder support: the parties will enter into a Company Lock-Up Agreement restricting transfers for 12 months after the Closing (subject to a price-based release at $12.00 for twenty Trading Days within any thirty consecutive Trading Day period, commencing at least 150 days after Closing), and certain Sakuu shareholders will enter Company Support Agreements to vote in favor of the Business Combination.

Why it may matter

• This filing reports Item 1.01 (entry into a material definitive agreement) and describes the proposed domestication, merger mechanics, Transaction Consideration, conversion of securities, earnout incentive shares, sponsor commitments, shareholder voting and lock-up arrangements, required filings including a Form S-4 and proxy statement, and closing conditions including minimum Net Closing Cash and listing approvals. The filing states customary representations, warranties, covenants, survival and termination provisions and that certain exhibits have been filed with the 8-K.

This filing does not explain why the company acted or why the insider traded.